Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000177

Drug Information
NameDoxepin    
SynonymsAC1LDI5F; Spectrum2_000133; Doxepin (Z)-isomer; CID667477; Doxepinum [INN-Latin]; KBioGR_001131; LS-174582; Doxepina [INN-Spanish]; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz(b,e)oxipin; NCGC00162127-01; Quitaxon; BPBio1_000118; KBio2_006421; Tocris-0508; 11-(3-(Dimethylamino)propylidene)-6H-dibenz(b,e)oxepine; Sinequan; Lopac0_000339; CHEBI:4710; NCGC00024623-02; CID10039438; AKOS001582771; BRD-K36616567-003-01-5; (3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-di(methyl)propan-1-amine; SPBio_000206; Zonalon; CHEBI:36692; Prestwick0_000263; AC1L1FAW; Cidoxepin; NINDS_000431; Prestwick1_000263; UNII-5ASJ6HUZ7D; UNII-F96TTB8728; Dibenz(b,e)oxepin-.delta.11(6H),.gamma.-propylamine, N,N-dimethyl-; IDI1_000431; Spectrum4_000526; Dibenz(b,e)oxepin-.delta.(sup 11(6H)),.gamma.-propylamine, N,N-dimethyl-; DivK1c_000431; Doxepin, Hydrochloride; Doxepin (INN); CID5462131; MF 10; MolPort-005-933-834; KBioSS_001285; AC1NUW4A; Spectrum3_000407; CHEMBL101740; doxepin; NCGC00015344-01; NCGC00024623-01; C19H21NO; Doxepina; CID3158; Cidoxepinum; 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine; cis-doxepin; CAS-1229-29-4; D07875; MOLI001594; Doxepinum; HSDB 3069; AC1LDI63; Spectrum5_001051; N,N-Dimethyldibenz(b,e)oxepin-delta(11(6H),gamma)-propylamine; BRD-K37694030-003-02-8; 1-Propanamine, 3-dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-; NCGC00015344-02; 11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin; 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine; Dibenz(b,e)oxepin-delta(sup 11(6H)),gamma-propylamine, N,N-dimethyl-; Doxepin Hydrochloride,; BSPBio_001934; CID667468; (3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine; (3Z)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; CCRIS 9176; Sinequan (TN); MolPort-003-847-024; SPBio_002325; Cidoxepina; Spectrum_000805; L000699; C06971; (3E)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; 3607-18-9; BSPBio_000106; cis-N-(3-(6H-Dibenz(b,e)oxepin-11-yliden)propyl)-N,N-dimethylamin; DB01142; KBio1_000431; Doxepine; LS-61638; 1668-19-5; Oprea1_473232; NCGC00015344-04; 3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine; Lopac-D-4526; KBio3_001154; KBio2_001285; CHEBI:36691; Triadapin; Doxepin [USAN]; Prestwick2_000263; (Z)-Doxepin; Cidoxepin [INN]; (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine; BRD-K54462405-003-03-3; Prestwick3_000263; 1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-; KBio2_003853    
Trade NameAponal; Adapine; Deptran; Sinquan; Sinequan; Zonalon; Xepin    
CompanyPfizer Pharmaceuticals    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntidepressive Agents    
CAS NumberCAS 1668-19-5
FormularC19H21NO    
PubChem Compound IDCID 667477.    
PubChem Substance IDSID 158785.    
ChEBI4710;    
SuperDrug ATC IDN06AA12;    
SuperDrug CAS ID001668195;    
TargetHistamine H1 receptorInhibitor[2]
Ref 1Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. To Reference
Ref 2Novel therapeutic usage of low-dose doxepin hydrochloride. Expert Opin Investig Drugs. 2007 Aug;16(8):1295-305. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543